Symptomatic Elevations of Lactic Acid and Their Response to Treatment Manipulation in Human Immunodeficiency Virus–Infected Persons: A Case Series
Open Access
- 15 December 2001
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 33 (12) , 2072-2074
- https://doi.org/10.1086/323980
Abstract
Symptomatic lactic acidemia was seen in 5 human immunodeficiency virus-positive patients receiving combination therapy that included stavudine and ⩾1 other nucleoside. Peak venous lactic acid levels of 3.1–7.4 mmol/L (normal range, 0.5–2.1 mmol/L) were associated with fatigue and rapid weight loss, whereas withdrawal of antiretrovirals led to normalization of venous lactic acid levels, symptomatic improvement, and weight gain. Resumption of an altered therapeutic regimen, which did not include stavudine but did include other nucleosides in 4 of 5 cases, did not result in recurrence of the syndrome after up to 126 days.Keywords
This publication has 12 references indexed in Scilit:
- Thiamine for the treatment of nucleoside analogue-induced severe lactic acidosisPublished by Wolters Kluwer Health ,1999
- Severe lactic acidosis induced by nucleoside analogues in an HIV-infected man.Annals of Emergency Medicine, 1999
- Zidovudine-associated type B lactic acidosis and hepatic steatosis in an HIV-infected patient.Southern Medical Journal, 1999
- Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletionJournal of Hepatology, 1999
- Hepatic steatosis and lactic acidosis associated with stavudine treatment in an HIV patient: a case reportAIDS, 1997
- Zidovudine-induced fatal lactic acidosis and hepatic failure in patients with acquired immunodeficiency syndromeCritical Care Medicine, 1997
- Massive Hepatic Steatosis and Lactic Acidosis in a Patient with AIDS Who Was Receiving ZidovudineClinical Infectious Diseases, 1995
- Comparison of mitochondrial morphology, mitochondrial DNA content, and cell viability in cultured cells treated with three anti-human immunodeficiency virus dideoxynucleosidesAntimicrobial Agents and Chemotherapy, 1994
- Fulminant hepatitis with severe lactate acidosis in HIV‐infected patients on didanosine therapyJournal of Internal Medicine, 1994
- Fulminant Hepatic Failure Associated with 2′,3′-Dideoxyinosine (ddI)Annals of Internal Medicine, 1991